Global POC HIV Testing Market 2018-2022 - Technological Advances, Growing Collaborations and Partnerships & Presence of Government Funding - ResearchAndMarkets.com

DUBLIN--()--The "Global POC HIV Testing Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The Global POC HIV Testing Market to grow at a CAGR of 7.03% during the period 2018-2022.

Global POC HIV Testing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also includes a discussion of the Key vendors operating in this market. To calculate the market size, the report considers the revenue generated by sales of POC HIV testing equipment and consumables across the globe.

According to the report, one driver influencing this market is the increase in HIV affected population worldwide. The high prevalence of HIV increases the demand for HIV screening, which is contributing to the growth of the market across the globe. One trend affecting this market is the technological advances. Technology is one of the key success factors in the development of the healthcare industry and allows better monitoring and testing of HIV patients.

Further, the report states that one challenge affecting this market is the high product recalls. One of the most major challenges being faced by the vendors of the global POC HIV testing market is the high number of product recalls due to lack of efficacy test results and errors.

Market trends
  • Technological advances
  • Growing collaborations and partnerships
  • Presence of government funding

Key vendors

  • Abbott
  • BD
  • bioMrieux
  • Danaher
  • F. Hoffmann-La Roche

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Market Sizing

Part 06: Five Forces Analysis

Part 07: Market Segmentation By Product

Part 08: Regional Landscape

Part 09: Decision Framework

Part 10: Drivers And Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

Part 14: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/fspw26/global_poc_hiv?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Disease Testing

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Disease Testing